Which hedge funds own RLAY? RELAY THERAPEUTICS INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
8 of the hedge funds tracked by WhaleCreep disclosed a position in RLAY (RELAY THERAPEUTICS INC) in their Q2 2026 13F filings, worth $355.6m in total. The largest holder by portfolio weight is Casdin Capital at 15.0% of its book. 2 managers opened a new position this quarter: Moore Capital Management, Duquesne Family Office LLC.
8tracked managers holding
2opened this quarter
0exited this quarter
Which hedge funds hold RLAY? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Casdin Capital | Q2 2026 | 15.0% | $300.0m | 16,035,240 | 11% | added |
| Moore Capital Management | Q2 2026 | 0.2% | $7.7m | 414,005 | – | new |
| Duquesne Family Office LLC | Q2 2026 | 0.1% | $6.5m | 349,000 | – | new |
| Woodline Partners | Q2 2026 | 0.1% | $17.4m | 929,692 | 37% | added |
| Millennium Management | Q2 2026 | 0.0% | $11.1m | 591,675 | 70% | added |
| Citadel Advisors | Q2 2026 | 0.0% | $8.9m | 473,682 | 169% | added |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $3.6m | 192,399 | -71% | reduced |
| Marshall Wace | Q2 2026 | 0.0% | $333.8k | 17,843 | -98% | reduced |
How has hedge fund ownership of RLAY changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 8 | $355.6m |
| Q1 2026 | 6 | $171.5m |
| Q4 2025 | 5 | $239.2m |
| Q3 2025 | 5 | $147.4m |
| Q2 2025 | 4 | $94.7m |
| Q1 2025 | 5 | $62.4m |
| Q4 2024 | 6 | $51.3m |
| Q3 2024 | 5 | $82.3m |
| Q2 2024 | 6 | $65.4m |
| Q1 2024 | 7 | $82.8m |
| Q4 2023 | 6 | $92.9m |
| Q3 2023 | 7 | $66.6m |
| Q2 2023 | 4 | $84.6m |
| Q1 2023 | 4 | $105.8m |
| Q4 2022 | 4 | $58.3m |
| Q3 2022 | 6 | $135.8m |
Counts every tracked manager that disclosed RLAY in that quarter's filing, including managers that have since stopped filing.